Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial
Michael A. Ströhlein, Florian Lordick, Dominik Rüttinger, Klaus-Uwe Grützner, Oliver C. Schemanski, Michael Jäger, Horst Lindhofer, Michael Hennig, Karl-Walter Jauch, Christian Peschel, Markus M. Heiss
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
Michael A. Ströhlein, Florian Lordick, Dominik Rüttinger, Klaus-Uwe Grützner, Oliver C. Schemanski, Michael Jäger, Horst Lindhofer, Michael Hennig, Karl-Walter Jauch, Christian Peschel, Markus M. Heiss. "Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial." Onkologie (Basel) 34.3 (2011) 101-108